153 related articles for article (PubMed ID: 2652547)
1. Renal graft histology in patients treated with different doses of cyclosporine.
Wilczek HE; Bohman SO; Groth CG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
[No Abstract] [Full Text] [Related]
2. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
[No Abstract] [Full Text] [Related]
3. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
4. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
5. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
[No Abstract] [Full Text] [Related]
6. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine.
Junor BJ; More IA; Bradley JA; Briggs JD; Kyle KF; McGregor E; McMillan MA; Macpherson SG; Van der Merwe W; Rodger RS
Transplant Proc; 1989 Feb; 21(1 Pt 2):1677-9. PubMed ID: 2652549
[No Abstract] [Full Text] [Related]
7. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
[No Abstract] [Full Text] [Related]
8. Monitoring the response to anti-rejection therapy with serum neopterin.
Smillie AE; Rigby RJ; Petrie JJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
[No Abstract] [Full Text] [Related]
9. Recipient age--an important factor for the outcome of cadaver renal transplantation in patients treated with cyclosporine.
Lundgren G; Persson H; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Groth CG; Lindholm A; Weibull H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1653-4. PubMed ID: 2652541
[No Abstract] [Full Text] [Related]
10. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
[No Abstract] [Full Text] [Related]
11. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
[No Abstract] [Full Text] [Related]
12. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
Ebel H; Lange H
Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
[No Abstract] [Full Text] [Related]
13. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
14. A controlled trial of triple therapy in renal transplantation.
Salaman JR; Griffin PJ; Ross WB; Williams JD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
[No Abstract] [Full Text] [Related]
15. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
[No Abstract] [Full Text] [Related]
16. Cyclosporine (Cy) monotherapy after cadaveric renal transplantation.
Margreiter R; Bösmüller C; Spielberger M; Schmid T; Königsrainer A
Transplant Proc; 1989 Feb; 21(1 Pt 2):1591-3. PubMed ID: 2652518
[No Abstract] [Full Text] [Related]
17. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
[No Abstract] [Full Text] [Related]
18. Bone repair in cyclosporin treated renal transplant patients.
Wilmink JM; Bras J; Surachno S; van Heyst JL; van der Horst JM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1492-4. PubMed ID: 2652480
[No Abstract] [Full Text] [Related]
19. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G
Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226
[No Abstract] [Full Text] [Related]
20. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]